Akebia Therapeutics, Inc. (AKBA)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
As of 12:28PM EDT. Market open.
| Previous Close | 1.3300 |
| Open | 1.2500 |
| Bid | 1.2100 x 3600 |
| Ask | 1.2300 x 100 |
| Day's Range | 1.2250 - 1.3300 |
| 52 Week Range | 0.7800 - 2.4800 |
| Volume | |
| Avg. Volume | 5,150,458 |
| Market Cap | 256.754M |
| Beta (5Y Monthly) | 0.93 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.
Akebia Therapeutics First Quarter 2024 Earnings: Misses Expectations
Akebia Therapeutics ( NASDAQ:AKBA ) First Quarter 2024 Results Key Financial Results Revenue: US$32.6m (down 19% from...
- Zacks
Akebia Therapeutics (AKBA) Reports Q1 Loss, Misses Revenue Estimates
Akebia Therapeutics (AKBA) delivered earnings and revenue surprises of 0% and 20.72%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
When Can We Expect A Profit From Akebia Therapeutics, Inc. (NASDAQ:AKBA)?
With the business potentially at an important milestone, we thought we'd take a closer look at Akebia Therapeutics...
© 2024 Yahoo. All rights reserved.